Belgian Pharma Figures 2015, in a European Perspective
In 2015, Belgium continued to reinforce its leading position in Europe as a biopharmaceutical hub. This becomes apparent when a number of key indicators in 2015 are compared with figures of the previous year.
Belgium showed a growth well above the European average, in particular with regard to investments in R&D (+5.5%) and the employment of researchers (+2.86%). The following brochure also contains figures on Belgium's position in clinical trials, employment, exports and production.
![Become a member](/sites/default/files/styles/inline/public/2021-06/istock-1158419934.jpg?h=d1cb525d&itok=UsJ4CMcP)
Schrijf je in op onze nieuwsbrief
Wil je op de hoogte blijven van het reilen en zeilen binnen de farma-industrie, schrijf je dan in op onze nieuwsbrief!